Search Results - "Barnette, Dustyn A"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort by Datta, Arghya, Flynn, Noah R., Barnette, Dustyn A., Woeltje, Keith F., Miller, Grover P., Swamidass, S. Joshua

    Published in PLoS computational biology (01-07-2021)
    “…Drug-drug interactions account for up to 30% of adverse drug reactions. Increasing prevalence of electronic health records (EHRs) offers a unique opportunity…”
    Get full text
    Journal Article
  2. 2

    Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches by Barnette, Dustyn A., Davis, Mary A., Dang, Na L., Pidugu, Anirudh S., Hughes, Tyler, Swamidass, S. Joshua, Boysen, Gunnar, Miller, Grover P.

    Published in Biochemical pharmacology (01-10-2018)
    “…[Display omitted] Lamisil (terbinafine) may cause idiosyncratic liver toxicity through a proposed toxicological mechanism involving the reactive metabolite…”
    Get full text
    Journal Article
  3. 3

    CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches by Davis, Mary A, Barnette, Dustyn A, Flynn, Noah R, Pidugu, Anirudh S, Swamidass, S. Joshua, Boysen, Gunnar, Miller, Grover P

    Published in Chemical research in toxicology (17-06-2019)
    “…Lamisil (terbinafine) is an effective, widely prescribed antifungal drug that causes rare idiosyncratic hepatotoxicity. The proposed toxic mechanism involves a…”
    Get full text
    Journal Article
  4. 4

    Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin by Pouncey, Dakota L, Barnette, Dustyn A, Sinnott, Riley W, Phillips, Sarah J, Flynn, Noah R, Hendrickson, Howard P, Swamidass, S Joshua, Miller, Grover P

    Published in Frontiers in pharmacology (13-01-2022)
    “…Coumadin (R/S-warfarin) anticoagulant therapy is highly efficacious in preventing the formation of blood clots; however, significant inter-individual…”
    Get full text
    Journal Article
  5. 5

    Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam by Barnette, Dustyn A., Schleiff, Mary A., Datta, Arghya, Flynn, Noah, Swamidass, S. Joshua, Miller, Grover P.

    Published in Toxicology letters (01-03-2021)
    “…[Display omitted] •Quantitative kinetics revealed enzyme roles in meloxicam/sudoxicam metabolism.•Thiazole methyl substituent alters enzyme specificity for…”
    Get full text
    Journal Article
  6. 6

    Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam by Barnette, Dustyn A., Schleiff, Mary A., Osborn, Laura R., Flynn, Noah, Matlock, Matthew, Swamidass, S. Joshua, Miller, Grover P.

    Published in Toxicology (Amsterdam) (01-07-2020)
    “…[Display omitted] •Electron density increased modeled epoxidations but depended on substituent types.•Novel kinetics showed impact of thiazole methyl on…”
    Get full text
    Journal Article
  7. 7

    Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation by Barnette, Dustyn A., Davis, Mary A., Flynn, Noah, Pidugu, Anirudh S., Swamidass, S. Joshua, Miller, Grover P.

    Published in Biochemical pharmacology (01-12-2019)
    “…[Display omitted] Terbinafine N-dealkylation pathways result in formation of 6,6-dimethyl-2-hepten-4-ynal (TBF-A), a reactive allylic aldehyde, that may…”
    Get full text
    Journal Article
  8. 8

    Stereospecific Metabolism of R - and S -Warfarin by Human Hepatic Cytosolic Reductases by Barnette, Dustyn A, Johnson, Bryce P, Pouncey, Dakota L, Nshimiyimana, Robert, Desrochers, Linda P, Goodwin, Thomas E, Miller, Grover P

    Published in Drug metabolism and disposition (01-09-2017)
    “…Coumadin (rac-warfarin) is the most commonly used anticoagulant in the world; however, its clinical use is often challenging because of its narrow therapeutic…”
    Get full text
    Journal Article
  9. 9

    Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs cohort by Datta, Arghya, Flynn, Noah R, Barnette, Dustyn A, Woeltje, Keith F, Miller, Grover P, Swamidass, S. Joshua

    Published in PLoS computational biology (06-07-2021)
    “…Drug-drug interactions account for up to 30% of adverse drug reactions. Increasing prevalence of electronic health records (EHRs) offers a unique opportunity…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Modeling the Metabolism and Subsequent Reactivity of Drugs by Swamidass, S. Joshua, Matlock, Matthew, Le Dang, Na, Hughes, Tyler, Barnette, Dustyn A, Miller, Grover P.

    Published in The FASEB journal (01-04-2017)
    “…Abstract only Adverse drug reactions (ADRs) are dangerous and expensive. Idiosyncratic ADRs, especially the difficult to predict, rare and severe…”
    Get full text
    Journal Article